Impact of SGLT2 inhibitors on lower limb complications: a mendelian randomization perspective

• Váldodahkkit: Baixing Chen (Dahkki), Mingling Huang (Dahkki), Bin Pu (Dahkki), Hang Dong (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2024-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

BackgroundWhile Sodium-glucose cotransporter 2 (SGLT2) inhibitors are effective in managing diabetes and reducing cardiovascular risk, concerns about their association with lower limb complications, including, osteomyelitis, ulcers, and peripheral artery disease (PAD), persist. This study employs Me...